You have 9 free searches left this month | for more free features.

Non-small Cell Lung Cancer (NCSLC)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

NSCLC Trial in Shanghai

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 20, 2023

    NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Nintedanib, gefitinib, erlotinib, afatinib
    • (no location specified)
    Oct 2, 2023

    NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Yangzhou, Jiangsu, China
      People's hospital of northern jiangsu
    Sep 26, 2023

    Cancer, NSCLC (NSCLC) Trial in Worldwide (Cofetuzumab Pelidotin)

    Recruiting
    • Cancer
    • Non-small Cell Lung Cancer (NSCLC)
    • Cofetuzumab Pelidotin
    • Birmingham, Alabama
    • +25 more
    Jan 31, 2023

    Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

    Not yet recruiting
    • Stage II-IIIB(N2) Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 26, 2023

    Identify Resected Non-small-cell Lung Cancer With High Risk of

    Recruiting
    • Non-small Cell Lung Cancer Stage IIIA
    • Resected non small cell lung cancer
    • Toulouse, France
      Julien MAZIERES
    Feb 8, 2023

    Specific Protein Overexpression in Adult Non-Small Cell Lung

    Not yet recruiting
    • Non Small Cell Lung Cancer
      • (no location specified)
      Sep 29, 2023

      TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

      Not yet recruiting
      • Lung Cancer, Non-small Cell
      • Small Cell Lung Cancer
        • (no location specified)
        Nov 16, 2022

        Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

        Not yet recruiting
        • Metastatic Lung Non-Small Cell Carcinoma
        • +2 more
        • Cetuximab
        • +2 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Oct 2, 2023

        NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Tirelizumab;Chemotherapy monotherapy
        • (no location specified)
        Jul 27, 2023

        NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • (no location specified)
        Sep 6, 2023

        Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

        Recruiting
        • Non Small Cell Lung Cancer
        • +2 more
        • Port Saint Lucie, Florida
        • +1 more
        Aug 11, 2023

        NSCLC Trial in Guangzhou (BL-M07D1)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Nov 1, 2023

        NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • Crizotinib - Usual
        • Crizotinib - Study
        • Rockville, Maryland
          Medicine Invention Design, Inc. - IORG0007849
        Oct 5, 2023

        NSCLC Trial in Shanghai (SI-B001, SI-B003)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Shanghai, Shanghai, China
          Shanghai Pulmonary Hospital
        Jul 10, 2023

        Metabolic Response to Food in Advanced Lung Cancer

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Weight loss (%)
        • (no location specified)
        Jun 30, 2023

        NSCLC Trial in Beijing

        Recruiting
        • NSCLC
          • Beijing, China
            Yuyan Wang
          Oct 10, 2023

          Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

          Recruiting
          • Nonsmall Cell Lung Cancer
          • HS-10365 capsules
          • Shanghai, Shanghai, China
            Shanghai Chest Hospital
          Nov 22, 2023

          NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

          Not yet recruiting
          • NSCLC
          • Non-small Cell Lung Cancer
          • Apatinib + Fluzoparib
          • Apatinib + Fluzoparib + Adebrelimab
          • Guangzhou, Guangdong, China
            Sun Yat-Sen University Cancer Center
          Jun 27, 2023

          Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

          Not yet recruiting
          • Non-Small Cell Lung Cancer
          • Oslo, Norway
            Pfizer Norway
          Apr 17, 2023

          Resectable Lung Non-Small Cell Carcinoma Trial in Atlanta (procedure, radiation, other)

          Not yet recruiting
          • Resectable Lung Non-Small Cell Carcinoma
          • Biospecimen Collection
          • +2 more
          • Atlanta, Georgia
            Emory University Hospital/Winship Cancer Institute
          Aug 22, 2023

          NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

          Not yet recruiting
          • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
          • (no location specified)
          Aug 27, 2023

          NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

          Recruiting
          • Carcinoma, Non-Small-Cell Lung
          • Wuhan, Hubei, China
            Qian Chu
          Aug 18, 2023

          Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

          Recruiting
          • Nonsmall Cell Lung Cancer
          • +3 more
          • Genomically Guided Radiation Therapy (RT)
          • Tampa, Florida
            Moffitt Cancer Center
          May 23, 2023